Skip to content
MedGadget – Medical Technology and Healthcare News Website Logo

MedGadget

Where Medicine Meets Technology

  • Author
  • Contact Us
  • About Us
Top Stories
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Bristol Myers Squibb Q3 2026 results graphic about pipeline data
Posted inPharmaceutical

Bristol Myers Squibb Q3 2026 Results: What the Pipeline Data on CELMoDs and Admilparant Show

The Bristol Myers Squibb Q3 2026 results include CELMoD, admilparant and RYZ101 updates. What each result shows and what is pending.
Continue Reading
October 30, 2026
Laurus Labs Galenvs acquisition graphic about oligonucleotide technology
Posted inBio Technology

Laurus Labs Galenvs Acquisition: The Oligonucleotide and Nanoparticle Technology Behind the Deal

The Laurus Labs Galenvs acquisition buys oligonucleotide and nanoparticle skills. What the technology involves and what is not shown.
Continue Reading
October 30, 2026
Fortis Healthcare acquisition graphic about care quality in Bengaluru
Posted inHealthcare Services

Fortis Healthcare Acquisition of Suguna Hospital: What Consolidation Means for Care Quality in Bengaluru

The Fortis Healthcare acquisition adds 110 beds in north-west Bengaluru. What evidence says about hospital deals and quality.
Continue Reading
October 30, 2026
Top Categories
Healthcare IT
Healthcare IT
Medical Device
Medical Device
Pharmaceutical
Pharmaceutical
Graphic: VQW-765 Phase 3 trial, drug and placebo lines nearly identical on the primary endpoint
Posted inPharmaceutical

Vanda’s Experimental Social Anxiety Drug VQW-765 Fails Phase 3 Trial Endpoint

VQW-765 Phase 3 trial: no difference from placebo on public-speaking distress (65.6 vs 66.0). Design, results, caveats and what happens next.
October 16, 2026
Graphic: AVID Medical recall lot number 1658437, item KRIV26-02, FDA Class 1 recall lot check
Posted inMedical Device

FDA Classifies AVID Medical IV Start Kit Lot 1658437 Recall as Class I Over Fungal Contamination Risk

AVID Medical recall lot number: only lot 1658437 is Class I. What FDA records show, where they differ, and what hospitals must do.
October 16, 2026
Graphic: Pennsylvania measles outbreak October 2026, case count rising from 1,004 to 1,222 between 5 and 14 October
Posted inHealthcare Services

Pennsylvania Measles Outbreak Reaches 1,222 Cases as CDC Sends Additional Support

Pennsylvania measles outbreak October 2026: 1,222 cases, 225 hospitalisations, five confirmed deaths and a sixth under review, as of 14 October.
October 16, 2026
Graphic: West Nile virus deaths 2026, 130 deaths reported in EU countries by ECDC
Posted inHealthcare Services

West Nile Virus Cases Hit Record Levels in Europe in 2026 as Deaths Reach 130

West Nile virus deaths 2026: ECDC counts 130 deaths among 1,715 EU cases as of 7 October. Severity, risk groups, prevention and caveats.
October 16, 2026
Graphic: prostate cancer 4Kscore test risk dial, with up to $150 million of the Labcorp BioReference deal tied to test revenue
Posted inHealthcare Services

Labcorp to Acquire BioReference Health Assets for Up to $872 Million, Expanding Diagnostic Testing

Prostate cancer 4Kscore test: Labcorp ties up to $150M of its BioReference deal to the test. What the release says and what remains undisclosed.
October 16, 2026
Graphic: daraxonrasib pancreatic cancer, RASolute 302 median overall survival 13.2 months versus 6.7 months
Posted inPharmaceutical

EMA Committee Recommends Rasonque for Metastatic Pancreatic Cancer After Phase 3 Survival Gain

Daraxonrasib pancreatic cancer: RASolute 302 shows 13.2 vs 6.7 months survival; the CHMP backs Rasonque. Trial design, side effects and caveats.
October 16, 2026
Graphic: AI drug discovery 2026, AstraZeneca and insitro collaboration on target discovery for MASH and cardiomyopathies
Posted inBio Technology

AstraZeneca Signs AI Drug-Discovery Deal Worth Up to $1.5 Billion With insitro

AI drug discovery 2026: AstraZeneca and insitro target MASH and heart disease. $40M upfront, up to ~$1.46B in milestones. What the platform must prove.
October 16, 2026
Graphic: Zydus international expansion, Zydus and Sunshine joint venture for a Sri Lanka plant
Posted inPharmaceutical

Zydus Sunshine Lifesciences Plans $20 Million-Plus Pharmaceutical Plant in Sri Lanka

Zydus international expansion reaches Sri Lanka: a $20M-plus plant via a joint venture, operations from 2028. How it is built and what is unclear.
October 15, 2026
Graphic: ANB033 clinical trial in celiac disease, CD122 antibody blocking IL-15 and IL-2 signalling
Posted inPharmaceutical

First Tracks Reports Positive ANB033 Gluten-Challenge Results in Celiac Disease

ANB033 clinical trial: a CD122 antibody limited gluten-linked gut damage and symptoms in 32 celiac patients. Early data, key caveats.
October 15, 2026
Graphic: solid tumour therapies, a masked T-cell engager around a tumour cell, from the Vir and Gilead collaboration
Posted inLife Science

Solid Tumour Therapies Get a Promising Masked Engager Bet

Solid tumour therapies from Vir and Gilead: how masked T-cell engagers work, why solid cancers are hard, and what the $1.88B deal does not prove.
October 15, 2026

Posts pagination

Previous page 1 … 6 7 8 9 10 … 25 Next page

All Categories

  • Bio Technology
  • Healthcare IT
  • Healthcare Services
  • Life Science
  • Medical Device
  • Pharmaceutical
  • Press Releases
  • Uncategorized
Press Releases
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Posted inPress Releases

Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines

Firefly Neuroscience and NeuroSigma Expand Access to Non-Drug Pediatric ADHD Treatment
Posted inPress Releases

Firefly Neuroscience and NeuroSigma Expand Access to Non-Drug Pediatric ADHD Treatment

InSilicoTrials Joins ARPA-H CIRCLE Program to Advance Digital Health Through Critical Care Digital Twins
Posted inPress Releases

InSilicoTrials Joins ARPA-H CIRCLE Program to Advance Digital Health Through Critical Care Digital Twins

Grünenthal and DKSH Expand Pain Medicine Partnership Across Eight Asia-Pacific Markets
Posted inPress Releases

Grünenthal and DKSH Expand Pain Medicine Partnership Across Eight Asia-Pacific Markets

Copyright 2026 — MedGadget.
Scroll to Top